ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of apoE-deficient mice transplanted with apoE-expressing macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 3, 1999, Pages 525-530

  Boisvert, William A ^a   Black, Audrey S ^a   Curtiss, Linda K ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Department of Vascular Biology ^*  (United States)

Author keywords

apoA1; apoE; Atherosclerosis; Bone marrow transplantation

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN E; CHOLESTEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; AORTA VALVE; ARTICLE; ATHEROGENIC DIET; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0032974688     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.3.525     Document Type: Article

References (42)

1. Gordon D, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against heart disease: the Framingham Study. Am J Med. 1977;62:707-714.
2. Goldbourt U, Medalie JH. High density lipoprotein cholesterol and incidence of coronary hear disease: the Israeli Ischemic Heart Disease Study. Am J Epidemiol. 1979;109:296-308.
3. Keys A. α-Lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet. 1980;2:603-606.
4. Abbott RD, Wilson PWF, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction: the FraminghamStudy. Arteriosclerosis. 1988;8:207-211.
5. Jacobs DR Jr, Mebane IL, Bangdiwala SI, Criqui MH, Tyroler HA. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up study of the Lipid Research Clinics Prevalence Study. Am J Epidemiol. 1990;131:32-47.
6. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH. A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med. 1991;325:373-381.
7. Barter PJ, Rye K-A. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
8. Assmann G, Funke H. HDL metabolism and atherosclerosis. J Cardiovasc Pharmacol. 1990;16:S15-S20.
9. Genest J Jr, Bard J-M, Fruchart J-C, Ordovas JM, Schaefer EJ. Familial hypoalphalipoproteinemia in premature coronary artery disease. Arterioscler Thromb. 1993;13:1728-1737.
10. Glomset JA. The plasma lecithin-cholesterol acyltransferase reaction. J Lipid Res. 1968;9:155-167.
11. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
12. Gordon V, Innerarity TL, Mahley RW. Formation of cholesterol-and apoprotein E-enriched high density lipoproteins in vitro. J Biol Chem. 1983;258:6202-6212.
13. Vollmer E, Roessner A. In situ localization and distribution pattern of apolipoproteins in arterial walls: a comparative study in atherosclerosis and renal transplant arteriopathy. Curr Top Pathol. 1993;87:125-162.
14. Rosenfeld ME, Butler S, Ord V, Lipton BA, Dyer CA, Curtiss LK, Palinski W, Witztum JL. Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb. 1993;13:1382-1389.
15. O'Brien KD, Deeb SS, Ferguson M, McDonald TO, Allen MD, Alper CE, Chait A. Apolipoprotein E localization in human coronary atherosclerotic plaques by in situ hybridization and immunohistochemistry and comparison with lipoprotein lipase. Am J Pathol. 1994;144:538-548.
16. 125I-labeled serum lipoproteins in rat aorta. Z Zellforsch Microsc Anat. 1973;138:223-237.
17. Barkia A, Puchois P, Ghalim N, Torpier G, Ailhaud G, Fruchart J-C. Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells. Atherosclerosis. 1991;87:135-146.
18. Steinmetz A, Barbaras R, Ghalim N, Clavey V. Fruchart J-C, Ailhaud G. Human apolipoprotein A-IV binds to apolipoprotein A-I/A-II receptor sites and promotes cholesterol efflux from adipose cells. J Biol Chem. 1990;265:7859-7863.
19. Slotte JP, Oram JF, Bierman EL. Binding of high density lipoproteins to cell receptors promotes translocation of cholesterol from intracellular membranes to the cell surface. J Biol Chem. 1987;262: 12904-12907.
20. Johnson WJ, Kilsdonk EPC, von Tol A, Phillips MC, Rothblat GH. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII. J Lipid Res. 1991;32: 1993-2000.
21. Banka CL, Black AS, Curtiss LK. Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells. J Biol Chem. 1991;266:23886-23892.
22. Boisvert WA, Spangenberg J, Curtiss LK. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J Clin Invest. 1995;96:1118-1124.
23. Linton MF, Atkinson JB, Fazio S. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 1995;267:1034-1037.
24. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957; 226:497-509.
25. Gamble W, Vaughan M, Kruth HS, Avigan J. Procedure for determination of free and total cholesterol in micro-or nanogram amounts suitable for studies with cultured cells. J Lipid Res. 1978;19: 1068-1070.
26. Pitas RE, Mahley RW. Analysis of tissue lipoproteins. In: Converse CA, Skinner ER, eds. Lipoprotein Analysis. London, UK: Oxford University Press; 1992:215-242.
27. Tangirala RK, Rubin EM, Palinski W. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res. 1995; 36:2320-2328.
28. Fazio S, Babaev VR, Murray AB, Hasty AH, Carter KJ, Cleaves LA, Atkinson JB, Linton MF. Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages. Proc Natl Acad Sci U S A. 1997;94:4647-4652.
29. Kruth HS. Cholesterol deposition in atherosclerotic lesions. Subcell Biochem. 1997;28:319-362.
30. Nordestgaard BG, Tybjaerg-Hansen A, Lewis B. Influx in vivo of low density, intermediate density, and very low density lipoproteins into aortic intimas of genetically hyperlipidemic rabbits: roles of plasma concentrations, extent of aortic lesion, and lipoprotein particle size as determinants. Arterioscler Thromb. 1992;12:6-18.
31. Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V. High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest. 1989;60:455-461.
32. Badimon JJ, Badimon L., Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1234-1241.
33. Miyazaki A, Sakuma S, Morikawa W, Takiue T, Miake F, Terano T, Sakai M, Hakamata H, Sakamoto Y, Naito M, Ruan Y, Takahashi K, Ohta T, Horiuchi S. Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol. 1995;15:1882-1888.
34. Rubin EM, Krauss RM, Spangler EA, Verstuyft J, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
35. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci U S A. 1994;91:9607-9611.
36. Paszty C, Maeda N, Verstuyft J, Rubin EM. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J Clin Invest. 1994;94:899-903.
37. Duverger N, Kruth H, Emmanuel F, Caillaud J-M, Viglietta C, Castro G, Tailleux A, Fievet C, Fruchart J-C. Houdebine LM. Denefle P. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation. 1996;94:713-717.
38. Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res. 1998;39: 313-321.
39. Stein O, Dabach Y, Hollander G, Ben-Naim M, Halperin G, Breslow JL, Stein Y. Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice. Proc Natl Acad Sci U S A. 1997;94: 9820-9824.
40. Barbaras R, Grimaldi P, Negrel R, Ailhaud, G. Characterization of high-density lipoprotein binding and cholesterol efflux in cultured mouse adipose cells. Biochim Biophys Acta. 1986;888:143-156.
41. 3H]cholesterol efflux and uptake in cell culture. Biochim Biophys Acta. 1995;1257:174-180.
42. Stein O, Stein Y, Lefevre M, Roheim PS. The role of apolipoprotein A-IV in reverse cholesterol transport studied with cultured cells and liposomes derived from an ether analog of phosphatidylcholine. Biochim Biophys Acta. 1986;878:7-13.